{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:56:41Z","timestamp":1754153801868,"version":"3.41.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Gastric cancer (GC) poses a significant threat to human health. Despite considerable advancements in immunotherapy for GC, the effectiveness of current immunotherapeutic targets remains constrained by the heterogeneity of the tumor microenvironment and mechanisms of immune evasion. Consequently, the identification of novel immunotherapy targets has emerged as a critical area of research. This study investigates the potential of Pygo2 as a target for immunotherapy in GC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The expression and cell localization of Pygo2 in GC tissues were characterized by single cell sequencing, flow cytometry and mIHC. The relationship among Pygo2 expression and prognosis, immune microenvironment and immunotherapy effect was studied in 282 gastric cancer patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The findings indicate a significant upregulation of Pygo2 expression in GC tissues, particularly within tumor cells and T cells. Pygo2 expression in T cells is not only correlated with the advanced T stage and N stage but also inversely associated with patient survival. Additionally, overexpression of T cell Pygo2 resulted in a significant increase in TCF7, which suggested Pygo2<jats:sup>+<\/jats:sup> T cells might represent a subset of exhausted T cells. The study also demonstrated that the density of Pygo2<jats:sup>+<\/jats:sup> CD8<jats:sup>+<\/jats:sup> T cells is negatively correlated with the efficacy of immunotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Tumor-infiltrating Pygo2<jats:sup>+<\/jats:sup> T cells could be applied as a clinical prognosticator and a predictive biomarker for immunotherapy responsiveness to GC. These findings offer new therapeutic targets for the treatment of GC and provide fresh insights into cancer treatment strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1596434","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:56:33Z","timestamp":1753275393000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pygo2+ T cells possess immunosuppressive features and inferior immunotherapeutic response in gastric cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Weilong","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zibo","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global\u00a0cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.12.006","article-title":"Adjuvant radiotherapy for gastric cancer-end of the road","volume":"32","author":"Lordick","year":"2021","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","article-title":"Signaling pathways and therapeutic interventions in gastric cancer","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078876","article-title":"Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: rationale-305 randomised, double blind, phase 3 trial","volume":"385","author":"Qiu","year":"2024","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002467","article-title":"Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer","volume":"9","author":"Zeng","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35431-x","article-title":"Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21657","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-020-01090-4","article-title":"Current status of immune checkpoint inhibitors for gastric cancer","volume":"23","author":"Kono","year":"2020","journal-title":"Gastric Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202202937","article-title":"Tumor cell-intrinsic setd2 deficiency reprograms neutrophils to foster immune escape in pancreatic tumorigenesis","volume":"10","author":"Niu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216498","article-title":"Pumilio1 regulates npm3\/npm1 axis to promote pd-L1-mediated immune escape in gastric cancer","volume":"581","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1042\/BST20200393","article-title":"Structure and function of pygo in organ development dependent and independent wnt signalling","volume":"48","author":"Shi","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade4656","article-title":"Targeting the chromatin effector pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer","volume":"8","author":"Zhu","year":"2023","journal-title":"Sci Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0311","article-title":"Pygo2 regulates adiposity and glucose homeostasis via beta-catenin-axin2-gsk3beta signaling pathway","volume":"67","author":"Xie","year":"2018","journal-title":"Diabetes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.10","article-title":"Pygo2 activates mdr1 expression and mediates chemoresistance in breast cancer via the wnt\/beta-catenin pathway","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncogene"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00465-10","article-title":"Pygo2 associates with mll2 histone methyltransferase and gcn5 histone acetyltransferase complexes to augment wnt target gene expression and breast cancer stem-like cell expansion","volume":"30","author":"Chen","year":"2010","journal-title":"Mol Cell Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2910","article-title":"A pygopus 2-histone interaction is critical for cancer cell dedifferentiation and progression in Malignant breast cancer","volume":"80","author":"Saxena","year":"2020","journal-title":"Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23625","article-title":"Pygo2 increases proliferation and migration capacities through critical signaling pathways in esophageal squamous cell carcinoma","volume":"38","author":"Ardalan Moghadam Al","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113696","article-title":"Pygo2 activates brpf1 via pygo2-H3k4me2\/3 interaction to maintain Malignant progression in colon cancer","volume":"431","author":"Ling","year":"2023","journal-title":"Exp Cell Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2022.2149039","article-title":"Interference of efna4 suppresses cell proliferation, invasion and angiogenesis in hepatocellular carcinoma by downregulating pygo2","volume":"23","author":"Yuan","year":"2022","journal-title":"Cancer Biol Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-313075","article-title":"Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through gm-csf-pd-L1 pathway","volume":"66","author":"Wang","year":"2017","journal-title":"Gut"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0381","article-title":"Cd155t\/tigit signaling regulates cd8+ T-cell metabolism and promotes tumor progression in human gastric cancer","volume":"77","author":"He","year":"2017","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-346","article-title":"Abnormal expression of pygopus 2 correlates with a Malignant phenotype in human lung cancer","volume":"13","author":"Liu","year":"2013","journal-title":"BMC\u00a0Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3564","article-title":"An in vivo screen identifies pygo2 as a driver for metastatic prostate cancer","volume":"78","author":"Lu","year":"2018","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajur.2015.06.009","article-title":"Pygopus 2 promotes kidney cancer\u00a0os-rc-2 cells proliferation and invasion in vitro and in vivo","volume":"2","author":"Liu","year":"2015","journal-title":"Asian J Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/srep22066","article-title":"Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3k4me3 and promotion of mll1\/mll2 complex recruitment","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108968","article-title":"Normalization of tumor vasculature: A potential strategy to increase the efficiency of immune checkpoint blockades in cancers","volume":"110","author":"Shi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.216043","article-title":"Cd8(+) T cell exhaustion and cancer immunotherapy","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103245","article-title":"Sulfisoxazole elicits robust antitumour immune response along with immune checkpoint therapy by inhibiting exosomal pd-L1","volume":"9","author":"Shin","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104452","article-title":"Tumor derived extracellular vesicles drive T cell exhaustion in tumor microenvironment through sphingosine mediated signaling and impacting immunotherapy outcomes in ovarian cancer","volume":"9","author":"Gupta","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215598","article-title":"Pmn-mdscs accumulation induced by cxcl1 promotes cd8(+) T cells exhaustion in gastric cancer","volume":"532","author":"Zhou","year":"2022","journal-title":"Cancer Lett"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-010-9488-1","article-title":"The role of pygopus 2 in rat glioma cell growth","volume":"28","author":"Chen","year":"2011","journal-title":"Med Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05257-0","article-title":"Pd-1 combination therapy with il-2 modifies cd8(+) T cell exhaustion program","volume":"610","author":"Hashimoto","year":"2022","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted cd8(+) T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004034","article-title":"Checkpoint blockade-induced cd8+ T cell differentiation in head and neck cancer responders","volume":"10","author":"Zhou","year":"2022","journal-title":"J\u00a0Immunother Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-21-0515","article-title":"Reversing T-cell exhaustion in cancer: lessons learned from pd-1\/pd-L1 immune checkpoint blockade","volume":"10","author":"Budimir","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.immuni.2023.09.001","article-title":"Deletion of the inhibitory co-receptor ctla-4 enhances and invigorates chimeric antigen receptor T cells","volume":"56","author":"Agarwal","year":"2023","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108630","article-title":"Effect of immunotherapy on\u00a0the immune microenvironment in advanced recurrent cervical cancer","volume":"106","author":"Chen","year":"2022","journal-title":"Int\u00a0Immunopharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1596434\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:56:34Z","timestamp":1753275394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1596434\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2025.1596434"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1596434","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"article-number":"1596434"}}